Live surgery: the hybrid approach to coronary artery revascularization

Treatment of coronary 3 vessel disease can be complex in certain cases and might need a different approach from the usual treatment modality. The hybrid approach, a combination of minimal invasive endoscopic CABG (endo-CABG) and percutaneous coronary intervention (PCI), might be a valuable treatment option.

 

The departments of cardiothoracic surgery, cardiology, anesthesia and intensive care of the Jessa Hospital are pleased to invite you to their second international symposium titled ‘The hybrid approach to coronary artery revascularization’.

 

Different insights from both a surgical and a cardiologic point of view will be discussed, reinforced by direct live transmission of Hybrid PCI and surgery at the Jessa Hospital. We hope to show you a glimpse behind the scenes of our daily practice, where we bring

together ‘the best of both worlds’.

 

We look forward to welcoming you!

 

Program

08.30 – 09.00 

Registration

09.00 – 09.15 

Welcome (Dirk Ramaekers MD PhD – JESSA Belgium)

09.15 – 09.30

Introduction (Alaaddin Yilmaz MD – JESSA Belgium)

 
SESSION 1: Hybrid approach: The perspective of cardiology

09.30 – 11.00 

Live broadcast – PCI Hybrid (E. Benit MD – JESSA Belgium)

09.30 – 09.50 

Chronic Total Occlusion (Y. Bataille MD PhD – JESSA Belgium)

09.50 – 10.10 

Hybrid approach: surgical perspective (A. Sanoussi MD – CHR Citadelle Belgium)

10.10 – 10.30 

Fast track in cardiac surgery (S. Rex MD PhD - UZ Leuven)

10.30 – 10.50 

Removal of Ticagrelor during emergency heart surgery and reduction of complications and costs (S. Geidel MD PhD – Asklepios Klinik St George Hamburg Germany)

10.50 – 11.45 

Brunch Break

 
SESSION 2: Minimal invasive coronary and hybrid surgery

11.45 – 13.30 

Live broadcast – EndoCABG (A. Yilmaz MD – JESSA Belgium)

11.45 – 12.10 

Guidelines of myocardial revascularization: Hybrid cardiac procedures (A. Kaya MD PhD – JESSA Belgium)

12.10 – 12.25 

Hybrid cardiac procedures at JESSA Hospital (S. Van Genechten MD – JESSA Belgium)

12.25 – 12.40

Antiplatelet therapy in hybrid cardiac procedures:implications for surgery (J. Vandenbrande MD – JESSA Belgium)

12.40 – 13.00 

END Discussion (L. Jamaer MD - JESSA Belgium)

13.00 – 14.00 

Farewell drink